HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tseng, Y.-L. Articles by Cheng, F.-F. Search for Related Content PubMed PubMed Citation Articles by Tseng, Y.-L. Articles by Cheng, F.-F. Related Collections Mediastinum

Ann Thorac Surg 2003;76:1041-1045
© 2003 The Society of Thoracic Surgeons

---

Original article: general thoracic

Thymic carcinoma: involvement of great vessels indicates poor prognosis

^a Institute of Clinical Medicine, Tainan, Taiwan, China
^b Department of Surgery, Tainan, Taiwan, China
^c Institute of Public Health, Thoracic Division, Tainan, Taiwan, China
^d Department of Pathology, National Cheng Kung University Hospital, College of Medicine, Tainan, Taiwan, China

Accepted for publication April 8, 2003.

^* Address reprint requests to Dr Wu, Department of Surgery, National Cheng Kung University Hospital, No 138, Sheng-Li Rd, Tainan 70428, Taiwan, China
e-mail: tsengyl{at}mail.ncku.edu.tw

BACKGROUND: Thymic carcinoma is a rare, indolent, and invasive cancer. This study investigated the treatment results of thymic carcinoma and clinical prognostic factors.

METHODS: From June 1988 to January 2002, 38 patients were enrolled in this study with the diagnosis of thymic carcinoma in the Cheng-Kung University Hospital based on Rosai's and Muller-Hermelink's classification. Clinical and pathologic data were retrospectively reviewed. Survival analysis was performed using the Kaplan-Meier, log rank, and Wilcoxon tests. Statistical significance was defined as p < 0.05.

RESULTS: Pathology revealed 14 poorly differentiated, 6 moderately differentiated, and 8 well-differentiated squamous cell carcinomas; 8 lymphoepithelioma-like carcinomas; and 2 other carcinomas. Pathologic staging using the Masaoka system included 6 stage II, 23 stage III, and 9 stage IV patients. Six biopsies, five debulkings, and 27 complete resections were performed. All patients were followed from 15 months to 10 years 9 months, with an average of 53.8 months. Median survival time was 81 months, and median recurrence time was 52 months. Eighteen patients are still alive, and 7 are alive with disease. Well-differentiated squamous cell carcinoma had better prognosis than other carcinomas (p = 0.022). Complete resection significantly increased survival rate (p < 0.001). Tumor invasion of the superior vena cava, pulmonary vessels, or aorta were significant predictors for poor prognosis (p = 0.016, 0.002, and 0.002, respectively).

CONCLUSIONS: Only patients with thymic carcinoma who underwent complete resection had long-term survival. Prognosis of thymic carcinoma seemed mainly dependent on tumor invasion of the great vessels.

This article has been cited by other articles:

				M. Yoshioka, O. Ichiguchi, T. Hirayama, T. Sassa, and T. Kamio Radical Excision of Thymic Adenocarcinoma with Selective Cerebral Perfusion Ann. Thorac. Surg., April 1, 2008; 85(4): 1427 - 1429. [Abstract] [Full Text] [PDF]

				T. De Giacomo, G. Mazzesi, F. Venuta, and G.F. Coloni Extended operation for recurrent thymic carcinoma presenting with intracaval growth and intracardiac extension. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1364 - 1365. [Full Text] [PDF]

				M.-H. Wu, Y.-L. Tseng, F.-F. Cheng, and T.-S. Lin Thymic carcinoid combined with myasthenia gravis J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 584 - 585. [Full Text] [PDF]